Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Doctor Insta to raise USD 4 million towards India expansion

      Doctor Insta to raise USD 4 million towards India expansion

      Ruby Khatun Khatun26 Oct 2017 9:15 AM IST
      New Delhi: Doctor Insta, a video medicine platform announced its plans to raise the next round of funding of USD 4 million to further expand its...
      Amneal, Impax combine to creates diversified pharma company

      Amneal, Impax combine to creates diversified pharma company

      Ruby Khatun Khatun26 Oct 2017 9:05 AM IST
      BRIDGEWATER, New Jersey and HAYWARD, California: Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. announced that they have entered into a...
      AbbVie bets on Alzheimers immunotherapy with big biotech deal

      AbbVie bets on Alzheimers immunotherapy with big biotech deal

      Ruby Khatun Khatun26 Oct 2017 9:00 AM IST
      U.S. drugmaker AbbVie is betting on the potential of the body’s immune system to fight Alzheimer’s by signing a drug development deal worth more than...
      Panacea Biotec gets USFDA nod to launch Prasugrel tablets

      Panacea Biotec gets USFDA nod to launch Prasugrel tablets

      Ruby Khatun Khatun25 Oct 2017 10:17 AM IST
      New Delhi: Drug firm Panacea Biotec said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for...
      Lupin gets FDA approval for drug to treat Parkinson disease

      Lupin gets FDA approval for drug to treat Parkinson disease

      Ruby Khatun Khatun25 Oct 2017 10:12 AM IST
      MUMBAI: Pharma major Lupin on Tuesday said it has received final approval for its carbidopa tablets, used for treatment of idiopathic Parkinson's...
      Abbott gets FDA approval for first smartphone compatible insertable cardiac monitor

      Abbott gets FDA approval for first smartphone compatible insertable cardiac monitor

      Ruby Khatun Khatun25 Oct 2017 10:00 AM IST
      Abbott has secured U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first and only...
      AstraZeneca gets FDA approval for BYDUREON BCise Injectable medicine for Type-2 Diabetes

      AstraZeneca gets FDA approval for BYDUREON BCise Injectable medicine for Type-2 Diabetes

      Ruby Khatun Khatun25 Oct 2017 9:47 AM IST
      WILMINGTON, Del.: AstraZeneca announced that the US Food and Drug Administration (FDA) has approved BYDUREON® BCise™ (exenatide extended-release)...
      FDA warns Meridian of violations for lead-testing devices

      FDA warns Meridian of violations for lead-testing devices

      Ruby Khatun Khatun25 Oct 2017 9:30 AM IST
      The U.S. Food and Drug Administration (FDA) said on Monday it issued a warning letter to Meridian Bioscience Inc’s unit for several federal law...
      Smith and Nephew to buy Rotation Medical for up to 210 million dollars

      Smith and Nephew to buy Rotation Medical for up to 210 million dollars

      Ruby Khatun Khatun25 Oct 2017 9:12 AM IST
      LONDON: Medical technology group Smith and Nephew, which has been urged by activist investor Elliott Management to shed some operations according to...
      Fleming Labs Nawabpet facility comes under USFDA scanner

      Fleming Labs Nawabpet facility comes under USFDA scanner

      Ruby Khatun Khatun24 Oct 2017 11:00 AM IST
      New Delhi: The US health regulator has issued an import alert for the drugs and drug products manufactured by Hyderabad-based Fleming Laboratories at...
      Healthcare startup OHM Healthcare raises Pre-series A funding

      Healthcare startup OHM Healthcare raises Pre-series A funding

      Ruby Khatun Khatun24 Oct 2017 10:37 AM IST
      New Delhi: Delhi-based 17-year-old Vedaant Aggarwal's healthcare startup, OHM Healthcare, announced that it has raised an undisclosed amount of...
      Credihealth to invest Rs 100 crore to augment technology, infrastructure

      Credihealth to invest Rs 100 crore to augment technology, infrastructure

      Ruby Khatun Khatun24 Oct 2017 10:37 AM IST
      New Delhi: India's leading medical assistance company Credihealth on Monday announced its plans to invest Rs. 100 crore in the next three years to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok